HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

X-Box Binding Protein 1

A basic leucine zipper transcription factor that regulates expression of MHC CLASS II GENES through its binding to a conserved X-box DNA sequence in the promoter region. It regulates the expression of genes involved in the UNFOLDED PROTEIN RESPONSE.
Also Known As:
TREB-5 Protein; TREB5 Protein; Tax-Responsive Element-Binding Protein 5; XBP-1 Protein; XBP2 Protein; TREB 5 Protein; Tax Responsive Element Binding Protein 5; X Box Binding Protein 1; XBP 1 Protein
Networked: 200 relevant articles (4 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kaser, Arthur: 5 articles (01/2022 - 09/2013)
2. Rosenstiel, Philip: 4 articles (01/2022 - 09/2013)
3. Tschurtschenthaler, Markus: 4 articles (01/2022 - 09/2013)
4. Qin, Hai-Lin: 4 articles (07/2020 - 02/2015)
5. Wu, Lian-Qiu: 4 articles (07/2020 - 02/2015)
6. Zhang, Hai-Jing: 4 articles (07/2020 - 02/2015)
7. Zhang, Jing: 3 articles (10/2022 - 01/2020)
8. Aden, Konrad: 3 articles (01/2022 - 10/2020)
9. Blumberg, Richard: 3 articles (01/2022 - 10/2017)
10. Hu, Yanhua: 3 articles (01/2022 - 05/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Non-alcoholic Fatty Liver Disease
3. Parkinson Disease (Parkinson's Disease)
12/01/2013 - "Vitagene associated markers (heat shock protein 70 and thioredoxin-1) also showed a decaying expression pattern that paralleled reduced expression of the transcription factors Parkinson disease 7, Forkhead box O 3 and X-box binding protein 1 with a role in preserving brain redox status. "
11/25/2019 - "To observe the effect of electroacupuncture (EA) on behavioral changes, and expression of tyrosine hydroxylase (TH), α-synuclein(α-syn), transcription activating factor 6 (ATF6) and transcription factor X box binding protein 1 (XBP-1) in the substantia nigra of Parkinson's disease (PD) rats, so as to explore its mechanisms underlying improvement of motor function. "
11/25/2019 - "[Electroacupuncture improved locomotor function by regulating expression of tyrosine hydroxylase and α-synuclein proteins and transcription activating factor 6 and transcription factor X box binding protein 1 mRNAs in substantia nigra of rats with Parkinson's disease]."
12/01/2021 - ": 6OHDA: 6-hydroxydopamine; baf: bafilomycin A1; BECN1: beclin 1; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2; CASP3: caspase 3; CCCP: carbonyl cyanide chlorophenylhydrazone; COX8A: cytochrome c oxidase subunit 8A; DDIT3/CHOP: DNA damage inducible transcript 3; EGFP: enhanced green fluorescent protein; ER: endoplasmic reticulum; ERN1/IRE1α: endoplasmic reticulum to nucleus signaling 1; FACS: fluorescence-activated cell sorting; HSPD1/HSP60: heat shock protein family D (Hsp60) member 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MFN2: mitofusin 2; OPTN: optineurin; PD: Parkinson disease; PINK1: PTEN-induced kinase 1; PCR: polymerase chain reaction:; PRKN: parkin RBR E3 ubiquitin protein ligase; XBP1s [p-S61A]: XBP1s phosphorylated at serine 61; XBP1s [p-T48A]: XBP1s phosphorylated at threonine 48; shRNA: short hairpin RNA, SQSTM1/p62: sequestosome 1; TIMM23: translocase of inner mitochondrial membrane 23; TM: tunicamycin; TMRM: tetramethyl rhodamine methylester; TOMM20: translocase of outer mitochondrial membrane 20; Toy: toyocamycin; TP: thapsigargin; UB: ubiquitin; UB (S65): ubiquitin phosphorylated at serine 65; UPR: unfolded protein response, XBP1: X-box binding protein 1; XBP1s: spliced X-box binding protein 1."
01/01/2021 - ": ADK: adenosine kinase; AMPK: AMP-activated protein kinase; ATF4: activating transcription factor 4; BECN1: beclin-1; DDIT3/CHOP: DNA damage inducible transcript 3; EIF2AK3/PERK: eukaryotic translation initiation factor 2 alpha kinase 3; EIF2S1/eIF2α: eukaryotic translation initiation factor 2 subunit alpha; ER: endoplasmic reticulum; ERN1/IRE1α: endoplasmic reticulum to nucleus signaling 1; FDA: Food and Drug Administration; GSH: glutathione; HD: Huntington disease; HSPA5/GRP78: heat shock protein family A (Hsp70) member 5; HTT: huntingtin; JAK: Janus kinase, MAP1LC3B/LC3: microtubule associated protein 1 light chain 3 beta; MAP2K/MEK: mitogen-activated protein kinase kinase; MAP3K8/Tpl2: mitogen-activated protein kinase kinase kinase 8; MAPK: mitogen-activated protein kinase; MPP+: 1-methyl-4-phenylpyridinium; MTOR: mechanistic target of rapamycin kinase; MTORC: MTOR complex; NAC: N-acetylcysteine; NGF: nerve growth factor 2; NMDA: N-methyl-D-aspartate; PCA: principal component analysis; PD: Parkinson disease; PDA: pancreatic ductal adenocarcinoma; PIK3C3: phosphatidylinositol 3-kinase catalytic subunit type 3; PMA: phorbol 12-myristate 13-acetate; PRKC/PKC: protein kinase C; ROCK: Rho-associated coiled-coil protein kinase; RR: ribonucleotide reductase; SIGMAR1: sigma non-opioid intracellular receptor 1; SQSTM1/p62: sequestosome 1; STK11/LKB1: serine/threonine kinase 11; TFEB: Transcription factor EB; TGFB/TGF-β: Transforming growth factor beta; ULK1: unc-51 like autophagy activating kinase 1; XBP1: X-box binding protein 1."
4. Hematoma
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Transcription Factors (Transcription Factor)
3. Inositol (Myoinositol)
4. Enzymes
5. Phosphotransferases (Kinase)
6. Interleukin-17 (Interleukin 17)
7. Cytokines
8. Tryptases (Tryptase)
9. Synucleins
10. Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)

Related Therapies and Procedures

1. Electroacupuncture
2. Therapeutics
3. Drug Therapy (Chemotherapy)
4. Highly Active Antiretroviral Therapy (HAART)
5. Acupuncture Points (Acupuncture Point)